Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor receptor 3c (FGFR3c) is an isoform of the FGFR3 protein, a receptor tyrosine kinase that regulates cell proliferation, differentiation, and development. It is predominantly expressed in mesenchymal tissues and has distinct FGF ligand affinities. Mutations or overexpression of FGFR3, including FGFR3c, are implicated in skeletal disorders and cancer, making it a therapeutic target. Upon activation, FGFR3c triggers intracellular signaling cascades like Ras/MAPK/ERK, PI(3)K/Akt, and PLCγ/PKC pathways.
Upon ligand binding, FGFR3c dimerizes, activates its tyrosine kinase activity, and phosphorylates downstream targets, activating the Ras/MAPK/ERK, PI(3)K/Akt, and PLCγ/PKC pathways, influencing gene expression related to growth and development.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast Growth Factor Receptor 3c (FGFR3c).